DSGN – design therapeutics, inc. (US:NASDAQ)

News

Design Therapeutics to Participate in Multiple Upcoming Investor Conferences
Design Therapeutics GAAP EPS of -$0.23 beats by $0.02 [Seeking Alpha]
Design Therapeutics Announces Third Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACTM Portfolio
We're Hopeful That Design Therapeutics (NASDAQ:DSGN) Will Use Its Cash Wisely [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com